Publicacións en colaboración con investigadores/as de Universidad Rey Juan Carlos (21)

2024

  1. Erratum to «Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper» (Archivos de Bronconeumología (2024) 60(3) (161–170), (S0300289624000061), (10.1016/j.arbres.2024.01.004))

    Archivos de Bronconeumologia

  2. Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper

    Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 161-170

  3. Surveillance of invasive pneumococcal disease in Spain exploring the impact of the COVID-19 pandemic (2019-2023)

    Journal of Infection, Vol. 89, Núm. 2

2023

  1. Addressing influenza’s underestimated burden – Iberian experts call to action

    BMC Infectious Diseases

  2. Excess hospitalizations and mortality associated with seasonal influenza in Spain, 2008–2018

    BMC Infectious Diseases, Vol. 23, Núm. 1

  3. Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain

    Infectious Diseases and Therapy, Vol. 12, Núm. 1, pp. 157-175

  4. Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group

    Antibiotics, Vol. 12, Núm. 1

2022

  1. A tool for early estimation of influenza vaccination coverage in Spanish general population and healthcare workers in the 2018–19 season: the Gripómetro

    BMC Public Health, Vol. 22, Núm. 1

  2. Clinical and economic burden of physician-diagnosed influenza in adults during the 2017/2018 epidemic season in Spain

    BMC Public Health, Vol. 22, Núm. 1

2021

  1. Vaccination against community acquired pneumonia in adults. Update 2021 of the position paper by Neumoexpertos en Prevención Group

    Semergen, Vol. 47, Núm. 6, pp. 411-425

2020

  1. From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain

    PLoS ONE, Vol. 15, Núm. 5

2019

  1. Differences between diabetic and non-diabetic patients with community-acquired pneumonia in primary care in Spain

    BMC Infectious Diseases, Vol. 19, Núm. 1

  2. El nuevo calendario vacunal oficial del adulto no contempla la prevención de la neumonía neumocócica

    Revista Espanola de Quimioterapia

  3. Lifestyle and comorbid conditions as risk factors for community-acquired pneumonia in outpatient adults (NEUMO-ES-RISK project)

    BMJ Open Respiratory Research, Vol. 6, Núm. 1

2018

  1. Adult community acquired pneumonia vaccination: 2018 Update of the positioning of the Pneumonia Prevention Expert Group

    Semergen, Vol. 44, Núm. 8, pp. 590-597

2017

  1. Erratum to: Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project), [BMC Infect Dis 16 (2016) (645)], DOI: 10.1186/s12879-016-1974-4

    BMC Infectious Diseases

2016

  1. Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project)

    BMC Infectious Diseases, Vol. 16, Núm. 1

2014

  1. Erratun :Prevention of serogroup B meningococcal disease using a four-component vaccine (Anales de Pediatria (2014) 80 (259e1-259e23) DOI: 10.1016/j.anpedi.2013.04.013)

    Anales de Pediatria

  2. Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de cuatro componentes

    Pediatria de Atencion Primaria, Vol. 16, Núm. 62

  3. Prevention of serogroup B meningococcal disease using a four-component vaccin

    Anales de Pediatria, Vol. 80, Núm. 4